NDC codes

415464 NDC codes with hospital pricing data in the network.

• NDC 45802-0004-03 — HYDROCORTISONE 2.5 % TOPICAL CREAMAI (391 hospitals, 31,075–32,128 samples)
• NDC 70756-0609-15 — Ofloxacin 0.3% ear dropsAI (457 hospitals, 30,965–32,126 samples)
• NDC 63323-0519-02 — Heparin in sodium chloride IV solutionAI (261 hospitals, 30,072–32,124 samples)
• NDC 00944-0493-01 — Human albumin 25% injectionAI (593 hospitals, 25,371–32,121 samples)
• NDC 63323-0494-16 — Valproate sodium 500 mg/5 mL intravenous solutionAI (264 hospitals, 30,954–32,106 samples)
• NDC 00409-1596-01 — Dexmedetomidine IV infusion in sodium chlorideAI (275 hospitals, 31,015–32,104 samples)
• NDC 70121-1399-05 — Dexamethasone sodium phosphate injectionAI (62 hospitals, 30,230–32,102 samples)
• NDC 65862-0496-47 — Sulfamethoxazole-trimethoprim oral suspensionAI (691 hospitals, 30,391–32,101 samples)
• NDC 45802-0244-14 — Nystatin-triamcinolone ointmentAI (307 hospitals, 31,048–32,083 samples)
• NDC 63323-0462-02 — Bupivacaine with epinephrine local anesthetic injectionAI (80 hospitals, 31,119–32,082 samples)
• NDC 00904-7193-61 — Famotidine 20 mg tabletsAI (670 hospitals, 31,234–32,080 samples)
• NDC 00168-0003-15 — Triamcinolone 0.025% topical creamAI (398 hospitals, 31,017–32,079 samples)
• NDC 00406-9112-76 — Fentanyl 12 mcg/hr transdermal patchAI (477 hospitals, 31,223–32,060 samples)
• NDC 45802-0048-35 — Nystatin 100,000 unit per gram ointment, 15 gram tubeAI (613 hospitals, 30,812–32,054 samples)
• NDC 69238-1532-05 — CLOBETASOL 0.05 % TOPICAL CREAMAI (317 hospitals, 31,088–32,051 samples)
• NDC 00713-0326-15 — BETAMETHASONE VALERATE 0.1 % TOPICAL CREAMAI (153 hospitals, 31,067–32,048 samples)
• NDC 65219-0188-10 — Ketamine 50 mg/mL injectionAI (173 hospitals, 31,067–32,048 samples)
• NDC 00487-9904-25 — Albuterol sulfate nebulizer solutionAI (347 hospitals, 30,928–32,044 samples)
• NDC 49502-0605-95 — Formoterol fumarate 20 mcg nebulizer solutionAI (245 hospitals, 31,081–32,044 samples)
• NDC 00168-0002-15 — TRIAMCINOLONE ACETONIDE 0.5 % TOPICAL CREAMAI (336 hospitals, 31,023–32,040 samples)
• NDC 00065-0395-15 — CYCLOPENTOLATE 0.5 % EYE DROPSAI (377 hospitals, 30,975–32,037 samples)
• NDC 24208-0434-05 — Ofloxacin 0.3% eye dropsAI (489 hospitals, 30,815–32,030 samples)
• NDC 00487-2784-01 — Racepinephrine inhaled nebulizer solutionAI (561 hospitals, 31,071–32,016 samples)
• NDC 51672-1318-01 — CICLOPIROX 0.77 % TOPICAL CREAMAI (137 hospitals, 31,033–32,014 samples)
• NDC 00121-0873-32 — Lactulose oral solution 10 g per 15 mLAI (202 hospitals, 30,941–32,012 samples)
• NDC 45802-0562-01 — Clindamycin phosphate 1% topical solution, 30 mL bottleAI (395 hospitals, 30,927–32,007 samples)
• NDC 50383-0233-10 — Dorzolamide and timolol eye dropsAI (283 hospitals, 31,062–31,998 samples)
• NDC 00409-1596-10 — Dexmedetomidine IV infusion in salineAI (193 hospitals, 30,996–31,986 samples)
• NDC 61314-0547-03 — Latanoprost 0.005% eye dropsAI (306 hospitals, 30,942–31,968 samples)
• NDC 60505-6226-01 — atropine 1 % eye dropsAI (402 hospitals, 31,058–31,958 samples)
• NDC 00338-9555-24 — Dexmedetomidine IV sedation solution, 200 mcg per 50 mLAI (187 hospitals, 30,615–31,956 samples)
• NDC 51672-1259-01 — Clobetasol 0.05% ointment, 15 g tubeAI (506 hospitals, 30,938–31,955 samples)
• NDC 00409-1660-50 — Dexmedetomidine IV infusion in salineAI (342 hospitals, 30,314–31,952 samples)
• NDC 42571-0147-26 — Dorzolamide-timolol eye drops, 2% and 0.5%AI (466 hospitals, 30,947–31,946 samples)
• NDC 00409-1559-30 — Bupivacaine 0.25% preservative-free injectionAI (253 hospitals, 30,082–31,945 samples)
• NDC 00487-5901-99 — Racemic epinephrine nebulizer solutionAI (1005 hospitals, 29,835–31,941 samples)
• NDC 16714-0557-01 — Metronidazole 0.75% vaginal gelAI (191 hospitals, 30,920–31,937 samples)
• NDC 00065-0397-05 — CYCLOPENTOLATE 2 % EYE DROPSAI (261 hospitals, 30,920–31,937 samples)
• NDC 00574-4024-39 — Erythromycin eye ointmentAI (139 hospitals, 30,805–31,930 samples)
• NDC 00185-0674-01 — Hydroxyzine pamoate 25 mg capsulesAI (317 hospitals, 31,322–31,925 samples)
• NDC 63323-0426-01 — Rocuronium bromide injection, 100 mg per 10 mLAI (151 hospitals, 30,788–31,922 samples)
• NDC 70095-0050-03 — Sodium bicarbonate 8.4% intravenous solutionAI (157 hospitals, 30,966–31,911 samples)
• NDC 00409-1966-07 — Bacteriostatic saline solution for injectionAI (541 hospitals, 31,179–31,890 samples)
• NDC 00378-3352-99 — Estradiol 0.1 mg/24 hr transdermal patchAI (390 hospitals, 30,985–31,876 samples)
• NDC 63739-0052-69 — CHLORHEXIDINE GLUCONATE 0.12 % MOUTHWASHAI (101 hospitals, 30,895–31,876 samples)
• NDC 16714-0019-30 — Budesonide 0.5 mg/2 mL nebulizer suspensionAI (103 hospitals, 30,895–31,876 samples)
• NDC 16714-0878-01 — Lidocaine 5% external ointmentAI (332 hospitals, 30,895–31,876 samples)
• NDC 33342-0405-35 — LIDOCAINE 5 % TOPICAL OINTMENTAI (212 hospitals, 30,895–31,876 samples)
• NDC 00409-0155-02 — Dexmedetomidine IV infusion in salineAI (39 hospitals, 30,895–31,876 samples)
• NDC 33342-0481-15 — Nystatin 100,000 unit topical ointmentAI (94 hospitals, 30,895–31,876 samples)